Teva Scores Earliest Generic License For Allergan's Linzess
Allergan PLC and Ironwood Pharmaceuticals Inc. have agreed to give Teva Pharmaceuticals USA a license to sell generic versions of the irritable bowel syndrome medication Linzess in March 2029, winning the...To view the full article, register now.
Already a subscriber? Click here to view full article